| 영문 | linear accelerator | 한글 | 선상가속기 |
|---|---|---|---|
| 설명 | 치료방사선과에서 이용하는 기계로서 전자를 생성해 낸다. 전자는 단순히 X-선과는 다른 것으로 전자가 금속에 부딪혀 나오는 것이 X-선이다. 전자는 진단목적보다는 치료목적으로 주로 피부의 악성종양(암)에 사용된다. |
||
| 영문 | rheumatoid factor | 한글 | 류마티스 인자 |
|---|---|---|---|
| 설명 | IgG의 Fc부위에 있는 항원결정인자에 대한 항체로서 전형적인 또는 확실한 류마티스관절염(rheumatoid arthritis) 환자의 80%에서 발견된다. 류마티스 인자는 IgM, IgG, IgA중 하나가 될 수 있으나 주로 IgM이다. 소아류마티스관절염(juvenile rheumatoid arthritis: 소아기에 발생하는 류마티스관절염)을 비롯한, 다른 결합조직병이나 감염병에도 나타날 수 있다 |
||
| 영문 | growth factor | 한글 | 성장인자 |
|---|---|---|---|
| 설명 | 세포의 분화 및 성장에 관여하는 단백질. 성장인자는 정상 세포주기에 필수적이기 때문에 동물의 생명에 중대한 요소가 된다. 무엇보다도 성장인자는 태아의 발육을 조정하고 조직의 유지 및 보수에 중대한 역할을 하며, 혈구의 생성을 자극한다. 또한 암의 진행과정에도 관여한다. |
||
| 영문 | risk factor | 한글 | 위험인자 |
|---|---|---|---|
| 설명 | 국제방사선방호위원회(ICRP)가 1977년 권고에서 방사선방호의 목적으로 채택한 지수로, 단위선량(1 Sv)당 확률적 영향의 발생확률을 추정하여 나타낸 것이다. 생식선 선량에 대한 유전적영향의 발생률(4×10－3/Sv)이나 적색골수선량에 대한 백혈병 발생률(2×10－3/Sv)등 외에 뼈, 허파, 갑상샘, 젖샘, 기타 조직의 위험지수를 측정하여, 확률적 영향의 전신에 있어서 치사위험지수의 합계를 16.5×10－3/Sv로 하였다. 그후 ICRP는 1990년 권고에서 대상이 되는 조직과 장기를 추가하고, 수치 개정을 하면서 명칭도 각목적확률지수라고하였다. 이 권고에 의하면, 치사적 확률적 영향의 확률지수의 합계는, 일반인에 있어 60.0×10－3/Sv이다. |
||
| CF | calcaneal fibular [ligament]; calcium leucovorin; calf blood flow; calibration factor; cancer-free; ... |
|---|---|
| PPCA | plasma prothrombin conversion accelerator; proserum prothrombin conversion accelerator |
| EF | ectopic focus; edema factor; ejection fraction; elastic fibril; electric field; elongation factor; e... |
| PF | pair feeding; peak flow; perfusion fluid; pericardial fluid; periosteal fibroblast; peritoneal fluid... |
| PAF | paroxysmal atrial fibrillation; peroxisomal assembly factor; phosphodiesterase-activating factor; pl... |
| AMS | Accelerator Mass Spectrometry |
|---|---|
| LINAC | Linear Accelerator |
| D factor | Differentiation-stimulating factor |
| TRAF | Factor Receptor-associated factor |
| FVIII-vWF | Factor VIII-von Willebrand Factor |
IGF-II : insulin like growth factor-II의 약자. 많은 장기와 조직에 작용하여 단백 합성과 DNA, RNA의 합성을 증가시켜 세포의 수와 양을 증가
| accelerator factor | <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease. Chemical name: Blood-coagulation factor V (12 Dec 1998) |
|---|
| accelerator | 1. Anything that increases rapidity of action or function. 2. In physiology, a nerve, muscle, or substance that quickens movement or response. 3. A catalytic agent used to hasten a chemical reaction. 4. In nuclear physics, a device that accelerates charged particles (e.g., protons) to high speed in order to produce nuclear reactions in a target, often for the production of radionuclides or for radiation therapy. Synonym: accelerant. Origin: L. Accelerans, pres. P. Of ac-celero, to hasten, fr. Celer, swift (05 Mar 2000) |
|---|---|
| accelerator fibres | Postganglionic sympathetic nerve fibre's originating in the superior, middle, and inferior cervical ganglia of the sympathetic trunk, conveying nervous impulses to the heart that increase the rapidity and force of the cardiac pulsations. Synonym: augmentor fibres. (05 Mar 2000) |
| accelerator globulin | Globulin in serum that promotes the conversion of prothrombin to thrombin in the presence of thromboplastin and ionised calcium. See: factor Va, factor V, serum accelerator globulin. (05 Mar 2000) |
| accelerator nerves | Certain of the cardiopulmonary splanchnic nerves establishing the sympathetic innervation of the heart; originating from ganglion cells of the superior, middle, and inferior cervical ganglion of the sympathetic trunk, the unmyelinated efferent fibres of the accelerator nerve's stimulate an increase in the heart rate. (05 Mar 2000) |
| railgun accelerator | <radiobiology> Projectile accelerator which accelerates the particle using electromagnetic forces which arise when the particle completes an electrical circuit between two conducting rails connected to a source of high current. (09 Oct 1997) |
| plasma accelerator globulin | <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease. Chemical name: Blood-coagulation factor V (12 Dec 1998) |
| proserum prothrombin conversion accelerator | A coagulation (clotting) factor. Classic haemophilia (haemophilia A) is due to a congenital deficiency in the amount (or activity) of factor VIII. Factor VIII is also known as antihemophiliac factor (AHF) or antihemophiliac globulin (AHG). The gene for factor VIII (that for classic haemophilia) is on the X chromosome so females can be silent carriers without symptoms and males can be haemophiliacs. (12 Dec 1998) |
| prothrombin accelerator | <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease. Chemical name: Blood-coagulation factor V (12 Dec 1998) |
| serum accelerator | <chemical> Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor viia in the extrinsic pathway of blood coagulation. The activated form then catalyses the activation of factor x to factor xa. Chemical name: Blood-coagulation factor VII (12 Dec 1998) |
| serum accelerator globulin | A substance in serum that accelerates the conversion of prothrombin to thrombin in the presence of thromboplastin and calcium; produced by the action of traces of thrombin upon plasma accelerator globulin. (05 Mar 2000) |
| serum prothrombin conversion accelerator | <chemical> Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor viia in the extrinsic pathway of blood coagulation. The activated form then catalyses the activation of factor x to factor xa. Chemical name: Blood-coagulation factor VII (12 Dec 1998) |
| linear accelerator | <apparatus> A sophisticated external beam radiotherapy machine which has the capabilities of focussing irradiation (although not very finely). Acronym: LinAC (16 Dec 1997) |
| acetate replacement factor | <biochemistry> 1,2 dithiolane 3 valeric acid. Regarded as a coenzyme in the oxoglutarate dehydrogenase complex of the citric acid cycle. Involved generally in oxidative decarboxylations of _ keto acids. A growth factor for some organisms. (18 Nov 1997) |
| adrenal weight factor | A postulated substance of adenohypophysial origin responsible for maintenance of the weight of the adrenal cortex. (05 Mar 2000) |
| adrenocorticotropic releasing factor | Hormone produced by hypothalamus that causes pituitary to secrete adrenocorticotropic hormone. (05 Mar 2000) |
| accelerator factor |
proaccelerin: a coagulation factor
출처: wordnet.princeton.edu/perl/webwn
|
|---|
| accelerator factor | a coagulation factor |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|